International World Snakebite Awareness Day 2022

Globally September 19th was observed as International World Snakebite Awareness Day. Snakebite envenoming (SBE) was added to the list of Neglected Tropical Diseases in 2017 by the World Health Organization (WHO), which also estimates that there are 4.5-5.4 million snakebites worldwide resulting in 1.8-2.7 million envenoming, 81,000-138,000 deaths, and permanent disabilities in 400,000 annually.

Nanoparticles: New Approach to Treat Snakebites
Nanoparticles were found to treat snakebites. Venomous snakebites affect 2.5 million people, and annually cause more than 100,000 deaths and leave 400,000 individuals with permanent physical and psychological trauma each year.

‘In order to be able to prevent death and complications awareness need be created in the community about snakebite, how it could be prevented, the first-aid measures and the value of anti-snake venom as the only available treatment for envenoming.’

Tweet it Now

India has the dubious distinction of accounting for half the number of snake bites, approximately two million and 58,000 deaths annually. Over 70 per cent of SBE occurs in males, typically in the productive ages of between 20 and 60 years and therefore having a tremendous socio-economic impact especially in case of death of the sole earning member of the family.

Snakebite Awareness

Doctors say the reasons for the neglect are many, including general lack of awareness with regards to snakebite among healthcare workers, community, etc.; the available polyvalent anti-snake venom not having the neutralizing effect against snake species of the northeast of India; victims in remote villages depending on traditional healers for treatment; and absence of a national protocol for treatment.

All these factors alongside the general apathy shown towards SBE by health policy makers, pharmaceutical industry, funding agencies and the health system in general, in spite of the considerable social ramifications is contributory.

The issues highlighted are more pronounced in the northeast as snake species here differ considerably from the rest of India and the effect of anti-snake venom against the common envenoming species like naja kaouthia (Monocellate cobra) and pit viper species is doubtful.

Snakebite can Put Millions at Risk Due to Lack of Anti-Venom Drug
People living in isolated areas are more prone to get bitten by venomous snakes and die due to lower access to anti-venom medications than those in an urban setting, study says.

The awareness campaign need percolate down into the community through schoolchildren, ASHA workers, etc.

Doctors need be trained on the immediate first-aid measures, signs and symptoms of envenoming, dosage of anti-snake venom and the pre-medications and complications.

Sanofi's Snakebite Serum Shortage Could Lead to Unnecessary Deaths: MSF
Fav-Afrique could no longer compete with cheaper alternatives flooding the market from Asia, Latin America and Africa.

In order to address this neglect and inequity, the Indian Council of Medical Research (ICMR) constituted a national task force for the study of incidence, morbidity, mortality and the socio-economic burden of snakebite in India.

The task force comprises Jaideep C. Menon, a cardiologist with the Amrita Institute of Medical Sciences in Kochi, Omesh K. Bharti, State Epidemiological Officer with Himachal Pradesh government and Santanu K. Sharma, Scientist G with Regional Medical Research Centre at Dibrugarh, Assam, India.

National Management Protocol For Doctors To Deal With Snakebites in India
India has the highest snake bite mortality in the world. The protocol aims to standardize treatment and use of anti-snake venom judiciously.

They are currently conducting a field trip for situational analysis in the four Indian northeastern states of Arunachal Pradesh, Meghalaya, Mizoram and Tripura.

Source-IANS